Jessica Kim Cohen

The Missouri hospital system designed its own 13-gene PGx panel, which it runs at its molecular genetics lab and calls the Kiddose PGx test.

The diagnostic firm's approach involves testing for tau that's bound to small lipid particles known as extracellular vesicles using its APEX platform.

Two blood-based biomarkers, percentage of p-tau 217 and amyloid-beta 42/40 ratio, predicted the presence of beta-amyloid plaque in patients' PET scans.

The myPGx panel adds pharmacogenomics testing services from Veritas Genetics, a company the firm acquired earlier this year, to LetsGetChecked's portfolio.

The company wants to commercialize its first antidepressant-matching service in 2023 and is hoping to launch it as an LDT in the US.